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HIGHLIGHTS

• Runx1 and CBFβ play independent roles in the establishment of the HSC lineage • Runx1 binding to CBFβ is not required for HE establishment
• CBFβ is downstream of BMP and regulates endogenous VEGFA expression in DH • Binding to Runx is not obligatory for CBFβ function
INTRODUCTION
Core binding factor (CBF), is a heterodimeric transcription factor (TF) complex composed of
one of the three runt-related DNA-binding α subunits (Runx1, Runx2, Runx3) and the non-DNA-binding β subunit (CBFβ) . The α subunits are capable of binding to DNA alone albeit at lower affinities compared to when complexing with CBFβ (Tang et al., 2000) . Additionally, CBFβ confers protein stability to the α subunits by preventing their ubiquitination and degradation by the proteasome (Huang et al., 2001; Park et al., 2016; Qin et al., 2015) . To date, CBFβ's transcriptional activity appears to be completely dependent on its physical interaction with the α subunits, i.e. its interaction with Runx is obligatory. (Bertrand et al., 2010; Boisset et al., 2010; Kissa and Herbomel, 2010) (Chen et al., 2009). Indeed, EHT in the zebrafish DA fails in the absence of Runx1 (Kissa and Herbomel, 2010 (Niki et al., 1997; Okuda et al., 1996; Wang et al., 1996) 
Runx proteins act as master regulators in different cell lineages with some overlapping functions. Of these, Runx1 has been established as a key regulator of hematopoiesis; in particular, Runx1 is essential for HSC generation. Runx1 is also frequently altered in chromosomal translocations associated with human leukemia
and is a critical regulator of haematopoietic-specific genes in a variety of blood cells. Runx1 expression during embryogenesis is prominent in the developing haematopoietic system and is needed in several hematopoietic processes such as megakaryocytic differentiation, erythropoiesis, B-and T-cell development; and, critically, the establishment of definitive hematopoiesis. HSCs are at the foundation of definitive hematopoiesis and they are transiently generated in the aorta-gonads-mesonephros (AGM) region of the midgestation embryo. Recent live imaging studies have demonstrated that HSCs are directly generated from a small cohort of HE cells localised in the ventral wall of the DA through a process termed as an endothelial to hematopoietic transition (EHT)
. Through conditional deletion, it has been demonstrated that Runx1 is specifically required for the generation of HSCs but not thereafter, indicating that it is an essential regulator of EHT
. In agreement, using a CBFβ-GFP, it has been determined that all c-kit hi cells from the fetal liver and the AGM, which contain
HSCs and nascent HSCs respectively, express CBFβ (Kundu et al., 2002 (Bresciani et al., 2014 (Cai et al., 2011; Miller et al., 2001; Wang et al., 2015 
RESULTS
Runx1 expression in the DA initiates before lumenisation and coincides with the loss of the venous program
Expression of Runx1 defines the hemogenic potential of endothelial cells Figure 1B ). This morphological change has also been described in the mouse DA and has been suggested to be indicative of the acquisition of hemogenic potential (Boisset et al., 2010; Bos et al., 2015; Mizuochi et al., 2012 Lyl1, Lmo2, SpiB, Gfi1, Ikzf1, Vav1 and Cebpα were expressed whereas Gata1, Gata3, Etv2, Etv6, PU1, SpiC, Gfi1b, aMyb, bMyb, cMyb, Mecom (Evi1) , CD41, CD45, Prom1 and CBFβ were not expressed (Figure 1C and S1 (Zhen et al., 2013 Figure 2A ), suggesting that it plays a role in this process.
Next we analysed the expression of arterial (Notch4, Dll4, Jag1, Efnb2 and Cx37), vein (Kdr, Flt4, Flt1, Fli1, Ets1, Erg, Elk3, Hhex, CD93, CD34, Ldb2, Pecam1, VWF and Cdh5) , and the endothelial expressed SoxF genes (Sox7, Sox17 and Sox18) . Some pan-endothelial and vein-affiliated genes were expressed from the DH stage (Tek, Flt1, Fli1, Erg, Elk3, Hhex, Kdr and Flt4) Figure S1 ). SoxF genes have been implicated in arterial specification and hematopoiesis, specifically in the regulation of Dll4 (Clarke et al., 2013; Corada et al., 2010) ; accordingly, Sox7, Sox17 and 
Sox18 are co-expressed with Dll4 in the DA. It is also important to note that the DA endothelium initially expresses both the arterial and vein programmes and that the vein program is lost concomitantly with the onset of Runx1 expression (Figure 1C
)
Runx1 is essential for haematopoietic expression in the DA
Although both Runx1 and CBFβ are required for the emergence of HSCs in the mouse DA,
only the expression of Runx1 has been examined in detail (Swiers et al., 2013) (Bresciani et al., 2014 (Denkinger et al., 2001; Huang et al., 2008; Lancrin et al., 2012; Okada et al., 1998) , are expressed soon after Runx1 initiates expression in the DA ( Figure 1C ), suggesting that
Runx1 is transcriptionally active in the absence of CBFβ. To test this, gene expression in the DA was analysed in Runx1 deficient embryos generated by the co-injection of two morpholino antisense oligonucleotides (MOs) which block the translation of the two protein
forms of Runx1, P1 and P2, generated by the usage of alternative promoters . Indeed, the expression of these genes was absent in the DA of Runx1 morphants ( Figure   2B ) and consequently a lack of IAC budding in the DA ( Figure S2D ). Additionally, the expression of Tal1-a, Lmo2 and Ikzf1 was also absent in these morphants ( Figure 2B ). Figure 2B ). (Hirai et al., 2005 (Walmsley et al., 2002) and HE starts to be established by day 4 of development, the Runx1 phenotype was rescued by transient transgenesis mediated by tol2 transposition (Urasaki et al., 2006 (Matheny et al., 2007; Roudaia et al., 2009 (Kirmizitas et al., 2017) . Furthermore, CBFβ has recently been identified as a target of BMP4 signaling in breast cancer cells (Ampuja et al., 2016) and is required for the proper activation of BMP signaling in chondrocytes (Park et al., 2016) 
Interestingly, expression of blood genes, whose expression initiates before the onset of
Runx1 in the DA (such as Gata2, Hhex and Tal1-b), is also absent in Runx1 morphants at stage 39, indicating that their expression becomes dependent on Runx1 (Figures 2C).
Furthermore, expression of Runx1 itself is missing when it is depleted, suggesting an auto regulatory loop (
Runx1 has been reported to repress Kdr expression in differentiating ES cells and endothelial cell lines
. Therefore, we investigated whether BMP controls CBFβ expression in the LPM. To this aim, embryos carrying a heat shock inducible
Noggin transgene (Beck et al., 2006) Kirmizitas et al., 2017; Nimmo et al., 2013) , including the inputs of CBFβ, is presented in Figure 6C . Figure 1A ) . In Figures 7A and S2F ).
CBFβ β β β programmes DH independently of its interaction with Runx
CBFβ function in the establishment of definitive hematopoiesis is thought to be dependent on its binding to Runx1. Here, we have shown that CBFβ is essential for the specification of DH in the LPM, a tissue where Runx1 is not expressed (
agreement, DH specification in Runx1 deficient embryos is unaffected (
As CBFβ transcriptional activity is thought to be strictly dependent on its binding to Runx proteins, we investigated whether Runx2 or Runx3 are expressed in the LPM. It has previously been reported that Runx2 is undetectable by RT-PCR in whole embryos at stage
25 (Kerney et al., 2007) . In agreement, ISH analysis showed that Runx2 is not expressed at the time DH is specified in the LPM ( Figure 7B) . Similarly, Runx3 expression has not been reported in the Xenopus LPM (Park and Saint-Jeannet, 2010 ) and our ISH analysis shows that it is exclusively expressed in the somites ( Figure 7C (Cunningham et al., 2012; Illendula et al., 2016) and one, Ro5-3335, has been successfully used in developing zebrafish embryos (Bresciani et al., 2014 (Park et al., 2016) .
As expected, head cartilage development was impaired in Ro5-3335 treated embryos (Figure 7G), indicating that this drug is indeed actively blocking the physical interaction between CBFβ and Runx proteins in Xenopus
embryos. 
In conclusion, we have discovered that CBFβ plays an essential role in the initiation of the HSC lineage and that this role is independent of its binding to Runx proteins. In other words, we have uncovered that CBFβ's transcriptional activity is not strictly dependent on Runx.
DISCUSSION
Runx1 marks HE in the ventral
Studies in differentiating ES cells have suggested that Runx1 represses Kdr expression in
HE (Hirai et al., 2005) 
. However, here we have demonstrated that Kdr repression in the DA is Runx1 independent (Figures 2D & S3F). This indicates that gene regulation in ES cellderived HE is different to that of the DA. Another discrepancy between ES-cell derived hematopoiesis and definitive hematopoiesis in the embryo concerns their hemangioblast precursors. It has been reported that in ES cells Runx1 is expressed by, and required for,
the specification of hemangioblasts (Lacaud et al., 2002 (Walmsley et al., 2002) .
Furthermore, while HE in the DA emerges from arterial endothelium, it has been suggested that definitive HE is not related to the arterial lineage in cultured human pluripotent stem cells (Ditadi et al., 2015) . Importantly, it has been reported that yolk sac HE can derive from venous rather than arterial endothelium (Frame et al., 2016) . Taken together, these strongly suggest that hematopoiesis in ES and iPS systems do not represent DA but rather yolk sactype hematopoiesis (Ivanovs et al., 2017 Figure 1C ) (Shrivastava et al., 2014) (Bresciani et al., 2014 (Kagoshima et al., 2007) (Kagoshima et al., 2007 
EXPERIMENTAL PROCEDURES
Morpholinos and TALENs
All MOs were obtained from GeneTools LLC (Corvallis, OR, USA). The Runx1 gene generates two main transcripts through the usage of two distinct promoters (P1 and P2),
specific MOs targeting the products of both promoters were designed (Figure S2) and injected in combination (40ng/embryo in total, 20ng/embryo each Figure S3 .
Embryo manipulation, in situ hybridization (ISH) procedures and Western blot analysis
Xenopus laevis embryos were obtained and cultured as described (Walmsley et al., 2005) and staged according to (Nieuwkoop and Faber, 1967) . A heat shock-inducible Noggin transgenic line (Beck et al., 2006) was used to generate BMP-deficient embryos; embryos were heat shocked and processed as previously indicated (Kirmizitas et al., 2017) . was dissolved in DMSO and treatments were performed at 75 µM, with DMSO as a vehicle. Embryo microinjection and whole mount ISH was performed as previously described (Walmsley et al., 2005) . Before photography, embryos were cleared in benzyl benzoate:benzyl alcohol (2:1). ISH to sectioned embryos was as previously indicated (CiauUitz et al., 2000) . For probe details see Table S1 .
Probes have been deposited into the European Xenopus Stock Centre, University of Portsmouth, UK. Protein extraction and
western blot analysis were as previously described (Afouda et al., 2005) ; CBFβ protein was detected using an anti-Human CBFβ antibody (abcam ab33516) , at a 1:1000 dilution.
Cloning and rescue experiments
cDNAs for wild-type mRunx1 as well as the mRunx1 mutants, R174Q and T161A, were kindly provided by Nancy Speck (Roudaia et al., 2009 (Kirmizitas et al., 2017 
